Loading provider…
Loading provider…
Urology Physician in Sacramento, CA
NPI: 1326134859Primary Practice Location
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER
4301 X St, Sacramento, CA
Primary Employer
UC Davis Medical Group
health.ucdavis.edu
HQ Phone
Get M.D. Marc's Phone Numberphone_androidMobile
Get M.D. Marc's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2006 - 2026
FL State Medical License
2021 - 2023
WA State Medical License
2000 - 2006

American Board of Urology
Urology
University of Washington
Residency • Urology
2000 - 2006
Residency • Surgery
2000 - 2002
UC Davis School of Medicine
health.ucdavis.edu
Medical School
Until 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 185 | 207 |
| 2 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 146 | 201 |
| 3 | 55700Biopsy of prostate gland | 105 | 106 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 102 | 106 |
| 5 | 76872Ultrasound of rectum | 98 | 98 |
Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006-2018: Effect of race, age and socioeconomic status on treatment disparities.
Authors: Onika Noel, Eric Stewart, Rosemary Cress, Marc Dall'era, Anshu Shrestha
Publication Date: 2023-01-06
Authors: Dall'Era, Marc A, De Vere White, Ralph W
Journal: Eur Urol
Publication Date: 2018-09-01
Molecular Characterization of Neuroendocrine-like Bladder Cancer
Authors: Seong Ra, Yair Lotan, Jason Efstathiou, Siamak Daneshmand
Journal: Clin Cancer Res
Publication Date: 2019-04-05
Lead Sponsor: Marc Dall'Era, MD
Collaborators: National Cancer Institute (NCI), Janssen, LP
Intervention / Treatment: DRUG: Niraparib, PROCEDURE: Radical Prostatectomy, DRUG: Niraparib Tosylate Monohydrate
Lead Sponsor: CG Oncology, Inc.
Intervention / Treatment: BIOLOGICAL: CG0070 Adenovirus Vector, OTHER: Control Arm: Quadruple Choice